A1c Goals for 70-Year-Old Patients with Type 2 Diabetes
For a 70-year-old patient with type 2 diabetes, the target HbA1c should be 7.5-8% if they have multiple comorbidities, and 8-9% if they are frail or have limited life expectancy (<5 years). 1
Target A1c Based on Patient Characteristics
The appropriate A1c target for older adults should be stratified based on their health status:
Healthy older adults (few comorbidities, good functional status, >5 years life expectancy)
- Target A1c: 7-7.5% 1
Patients with multiple comorbidities and moderate life expectancy
- Target A1c: 7.5-8% 1
Frail patients or those with limited life expectancy (<5 years)
- Target A1c: 8-9% 1
Rationale for Less Stringent Goals in Older Adults
Several factors support less stringent A1c goals in older adults:
Hypoglycemia risk: Older adults have increased risk of hypoglycemia due to renal insufficiency, polypharmacy, drug interactions, irregular meal patterns, and less frequent glucose monitoring 2
Time to benefit: Years of intensive glycemic control (HbA1c < 7%) are required before reduction in complications like kidney failure or blindness becomes evident 3
Fall risk: In individuals 70-79 years taking insulin, fall probability increases with HbA1c < 7% 3
Comorbidities: The presence of significant comorbidities may abrogate benefits of lower HbA1c 3
Important Considerations
Avoid symptomatic hyperglycemia: Even with less stringent A1c goals, it's important to prevent symptoms of hyperglycemia (polyuria, polydipsia, weight loss) 2
Medication selection: Prefer medications with lower hypoglycemia risk:
- Metformin (first-line unless contraindicated)
- SGLT2 inhibitors
- GLP-1 receptor agonists 1
Avoid high-risk medications:
- First-generation sulfonylureas (chlorpropamide, tolazamide, tolbutamide)
- Glyburide
- Rosiglitazone 2
Monitoring frequency:
- Every 6 months for patients not meeting targets
- Every 12 months for those with stable A1c 1
Special Considerations for Advanced Age
Normal HbA1c levels increase slightly with age, which should be considered when setting targets 1
The KDOQI guidelines suggest extending target HbA1c above 7.0% in individuals with comorbidities, limited life expectancy, and risk of hypoglycemia 3
Recent research indicates that older adults with A1c <7% were not at elevated mortality risk regardless of health status, challenging the assumption that very tight control is always harmful 4
Interestingly, one study found that higher A1c goals did not protect against hypoglycemia in older adults on insulin therapy 5
By carefully considering the patient's overall health status, comorbidities, and life expectancy, clinicians can select an appropriate A1c target that balances the benefits of glycemic control with the risks of treatment in 70-year-old patients with diabetes.